Myasthenia gravis: open trials in Austria

• NCT05374590

  Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis

  Trial Treatment · Phase 2/3 · argenx

  Medical University of Vienna, Vienna

  Registry updated 2026-11-03

• NCT07217587

  Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

  Trial Treatment · Phase 3 · Janssen Research & Development, LLC

  Medical University of Vienna, Vienna

  Registry updated 2026-11-03

• NCT07647510

  A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

  Trial Treatment · Phase 3 · Dianthus Therapeutics

  Johannes Kepler University Linz, Linz · Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · Kardinal Schwarzenberg Klinikum GmbH, Schwarzach Im Pongau · Klinikum Wels-Grieskirchen GmbH, Wels

  Registry updated 2026-10-30

• NCT04202341

  Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

  Research · Alexion Pharmaceuticals, Inc.

  Vienna

  Registry updated 2026-02-18

• NCT06298565

  A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

  Research · argenx

  Kepler Universitätsklinikum, Universitätsklinik für Neurologie, Med Campus III, Linz

  Registry updated 2026-02-17

All Myasthenia gravis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error